AUTL
Price
$1.28
Change
-$0.08 (-5.88%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
339.33M
116 days until earnings call
Intraday BUY SELL Signals
PRTC
Price
$16.34
Change
-$0.47 (-2.80%)
Updated
Nov 13 closing price
Capitalization
398.47M
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUTL vs PRTC

Header iconAUTL vs PRTC Comparison
Open Charts AUTL vs PRTCBanner chart's image
Autolus Therapeutics
Price$1.28
Change-$0.08 (-5.88%)
Volume$31.49K
Capitalization339.33M
PureTech Health
Price$16.34
Change-$0.47 (-2.80%)
Volume$1.64K
Capitalization398.47M
AUTL vs PRTC Comparison Chart in %
AUTL
Daily Signal:
Gain/Loss:
PRTC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUTL vs. PRTC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and PRTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AUTL: $1.36 vs. PRTC: $16.80)
Brand notoriety: AUTL and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 155% vs. PRTC: 46%
Market capitalization -- AUTL: $339.33M vs. PRTC: $398.47M
AUTL [@Biotechnology] is valued at $339.33M. PRTC’s [@Biotechnology] market capitalization is $398.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whilePRTC’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • PRTC’s FA Score: 1 green, 4 red.
According to our system of comparison, PRTC is a better buy in the long-term than AUTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 2 TA indicator(s) are bullish while PRTC’s TA Score has 3 bullish TA indicator(s).

  • AUTL’s TA Score: 2 bullish, 6 bearish.
  • PRTC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PRTC is a better buy in the short-term than AUTL.

Price Growth

AUTL (@Biotechnology) experienced а -1.81% price change this week, while PRTC (@Biotechnology) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AUTL is expected to report earnings on Mar 10, 2026.

PRTC is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($398M) has a higher market cap than AUTL($339M). PRTC YTD gains are higher at: -8.992 vs. AUTL (-42.128). PRTC has higher annual earnings (EBITDA): 37.8M vs. AUTL (-232.19M). AUTL has more cash in the bank: 454M vs. PRTC (322M). PRTC has less debt than AUTL: PRTC (20.9M) vs AUTL (64.5M). AUTL has higher revenues than PRTC: AUTL (29.9M) vs PRTC (6.17M).
AUTLPRTCAUTL / PRTC
Capitalization339M398M85%
EBITDA-232.19M37.8M-614%
Gain YTD-42.128-8.992468%
P/E RatioN/A9.61-
Revenue29.9M6.17M485%
Total Cash454M322M141%
Total Debt64.5M20.9M309%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLPRTC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signal:
Gain/Loss:
PRTC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOUTF0.06N/A
+7.41%
Southern Energy Corp.
PCCYF1.160.04
+3.57%
PetroChina Co., Ltd.
MLLCF3.60N/A
N/A
Molecular Partners AG
CMGMF7.23N/A
N/A
Chemring Group Plc.
MDBPF3.30N/A
N/A
MEDIBANK PRIVATE LTD

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-9.33%
CRSP - AUTL
44%
Loosely correlated
-5.47%
IMTX - AUTL
43%
Loosely correlated
+16.10%
IPSC - AUTL
43%
Loosely correlated
N/A
BCYC - AUTL
43%
Loosely correlated
-3.95%
OCUL - AUTL
42%
Loosely correlated
+2.41%
More

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and ZLAB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and ZLAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
+2.82%
ZLAB - PRTC
31%
Poorly correlated
-0.55%
RLMD - PRTC
31%
Poorly correlated
+18.84%
IRON - PRTC
30%
Poorly correlated
-0.06%
PTCHF - PRTC
29%
Poorly correlated
N/A
AUTL - PRTC
28%
Poorly correlated
-9.33%
More